Carotuximab
Product Specifications
CAS Number
1268714-50-6
Target
Immunology/Inflammation related, TGF-beta/Smad
Related Pathways
Stem Cells, Immunology/Inflammation
Purity
>95%
Bioactivity
Carotuximab (DE-122) is a novel endocholine antibody with strong antiangiogenic and anti-inflammatory activity. Carotuximab blocks endothelial glycoprotein (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antitumor effects to prevent human endothelial dysfunction induced by hypercholesterolemia and hyperglycemia.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog